Cancer experts have warned of a 'frightening' crisis as pharmaceutical companies abandon production of one of the most widely used chemotherapy drugs because it is not profitable enough.
Fluorouracil - also known as 5-FU - is one of the most frequently used components in chemo combinations used to treat bowel and breast cancer in the UK and worldwide.
But cancer specialists in Germany have warned that the drug has become increasingly difficult to obtain as producers turn to newer, more profitable treatments.
Read more:
http://www.dailymail.co.uk
